Orion said today that it plans to sell its Orion Diagnostica division to an investment fund managed by Axcel Management for $200 million.
The Finland-based company said its diagnostic unit operates independently from its pharmaceutical business and that the two groups have “material business synergies.”
Get the full story at our sister site, Drug Delivery Business News.
The post Orion inks $200m deal to sell diagnostics unit appeared first on MassDevice.